KalVista Pharmaceuticals Other Current Liabilities

KalVista Pharmaceuticals (KALV) currently reports a other current liabilities of $34M as of January 2026. That compares with $18M in the prior-year period — up 85.1% year over year. Use the charts on this page to explore KalVista Pharmaceuticals's other current liabilities history and peer comparisons.

KalVista Pharmaceuticals's other current liabilities increased from $18M to $34M — a 85.1% year-over-year increase (period ending January 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

KalVista Pharmaceuticals reported $34M in other current liabilities as of January 2026. That compares with $18M in the prior-year period — up 85.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $34M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for KalVista Pharmaceuticals, and consider following KALV for alerts when major investors trade the stock.

KalVista Pharmaceuticals is classified in the Healthcare sector. On other current liabilities, it currently shows $34M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KALV with unrelated industries.